Works matching IS 00283835 AND DT 2023 AND VI 113 AND IP 3


Results: 8
    1

    Front & Back Matter.

    Published in:
    Neuroendocrinology, 2023, v. 113, n. 3, p. 1, doi. 10.1159/000529950
    Publication type:
    Article
    2
    3

    Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy.

    Published in:
    Neuroendocrinology, 2023, v. 113, n. 3, p. 281, doi. 10.1159/000526848
    By:
    • Li, Minmin;
    • Chan, David L.;
    • Tapia Rico, Gonzalo;
    • Cehic, Gabrielle;
    • Lawrence, Ben;
    • Wyld, David;
    • Pattison, David A.;
    • Kong, Grace;
    • Hicks, Rodney;
    • Michael, Michael;
    • Kiberu, Andrew Ddembe;
    • Lim, Jennifer;
    • Clifton-Bligh, Roderick;
    • Tsang, Venessa;
    • Roach, Paul J.;
    • Leyden, John;
    • Diakos, Connie I.;
    • Price, Timothy J.;
    • Pavlakis, Nick
    Publication type:
    Article
    4
    5

    Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT Study.

    Published in:
    Neuroendocrinology, 2023, v. 113, n. 3, p. 332, doi. 10.1159/000526811
    By:
    • Ferolla, Piero;
    • Berruti, Alfredo;
    • Spada, Francesca;
    • Brizzi, Maria Pia;
    • Ibrahim, Toni;
    • Marconcini, Riccardo;
    • Giuffrida, Dario;
    • Amoroso, Vito;
    • La Salvia, Anna;
    • Vaccaro, Vanja;
    • Faggiano, Antongiulio;
    • Colao, Annamaria;
    • Volante, Marco;
    • Ghizzoni, Simona;
    • Mazzanti, Paola;
    • Houchard, Aude;
    • Fazio, Nicola
    Publication type:
    Article
    6
    7
    8